p53, p21 and p27 protein expression in head and neck cancer and their prognostic value

Anticancer Research

Volumn 21, Issue 1 B, 2001, Pages 521-528

  Kapranos, N ^a   Stathopoulos, G P ^a   Manolopoulos, L ^a   Kokka, E ^a   Papadimitriou, C O N ^a   Bibas, A ^a   Yiotakis, J ^a   Adamopoulos, G ^a  

^a NONE   (Greece)

Author keywords

Head and neck cancer; p21; p27 oncogenes; p53

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEIN P21; PROTEIN P27; PROTEIN P53;

ADULT; AGE; AGED; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEAD CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; NECK CANCER; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RISK ASSESSMENT; RISK FACTOR; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HEAD AND NECK NEOPLASMS; HUMANS; LIFE TABLES; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 0035056426     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. The p53 tumor suppressor gene
2. p53: The guardian of the genome
3. P53 mutations in human cancers
4. p53 in the tumor pathology: Can we trust immunohistochemistry?
5. Braking the cell cycle
6. Cyclins, cyclin-dependent kinases and cdk inhibitors: Implications in cell cycle control and cancer
7. The p21 Cdk-interacting protein Cip 1 is a potent inhibitor of G1 cyclin-dependent kinases
8. p21 is a universal inhibitor of cyclin kinases
9. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
10. WAF1, a potential mediator of p53 tumor suppression
11. Tumor suppression by p21WAF1
12. In vivo gene therapy with p53 or p51 adenovirus for prostate cancer
13. P27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
14. Cloning of p27KLP1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals
15. Dependence of cyclin E-CDK2 kinase activity on cell anchorage
16. p53 expression: Predicting recurrence and second primary tumors in head and neck squamous cell carcinoma
17. Expression of p53 and p21 proteins in oral squamous cell carcinoma: Correlation with lymph node metastasis and response to chemoradiotherapy
18. Immunohistochemical markers of cell cycle control applied to ovarian and primary peritoneal surface epithelial neoplasms: p21WAF/CIP1 predicts survival and good response to platinin-based chemotherapy
19. Non-parametric estimation from incomplete observations
20. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes
21. Frequent p53 mutations in head and neck cancer
22. Patterns of p53 gene mutations in head and cancer: Full-length gene sequencing and results of primary radiotherapy
23. Is p53 an independent prognostic factor in patients with laryngeal carcinoma?
24. p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma
25. Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy
26. WAF/CIP1 is induced in p53-mediated G1 arrest and apoptosis
27. Induction of WAF/CIP1 by a p53-independent pathway
28. WAF/Cip1 expression is associated with cell differentiation but not with p53 mutations in squamous cell carcinomas of the larynx
29. WAF/Cip1 is heterogeneous and unrelated to proliferation index in human ovarian carcinoma
30. WAF/Cip1 immunohistochemical expression in breast carcinoma: Correlations with clinico-pathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival
31. WAF/Cip1 in non-neoplastic mucosa and neoplasia of the stomach: Relationship with p53 status and proliferative activity
32. p21 (Waf/Cip 1) and 53 protein expression in breast cancer
33. WAF1 expression and p53 mutations in human colorectal cancers
34. p53 gene mutations and p21 protein expression induced independently of p53, by TGF-beta and gamma-rays in squamous cell carcinoma cells